Amplifon

Amplifon, a global leader in hearing care, has faced a 60% stock drop due to weak demand in EMEA and potential consequences of rising tariffs in the U.S. Despite recent struggles, Amplifon remains well-positioned in a growing market, with increasing demand for hearing aids expected to rise sharply by 2050. FY2024 results showed modest revenue growth but declining EBIT and Net Income; however, investments in France and USA are expected to boost profitability by 2025.» Mehr auf seekingalpha.com

Italian hearing aid company Amplifon reported an annual core profit margin of 23.6% on Thursday, short of its revised guidance of 24%, which along with a drop in net profit sent its shares falling 12%.» Mehr auf reuters.com

Amplifon S.p.A. is a global leader in hearing care services with 10,000 retail locations across 26 countries, offering a wide variety of hearing aid devices and personalized healthcare services. Despite a 50% stock price drop since November 2021, Amplifon is slightly undervalued, presenting a compelling entry point for long-term investors with a fair value of €30 per share. Amplifon's customer-centric approach, extensive global network, digital innovation, and strong M&A strategy position it for sustained market leadership and high single-digit to low teens revenue growth.» Mehr auf seekingalpha.com